Proteolytic processing of GH at sites of tissue damage and inflammation (e.g. in viral lung infection or osteoarthritis) to release C‐terminal fragments may represent an endogenous pathway to help limit inflammatory damage and promote recovery. The gene discussed is GH1; the disease is osteoarthritis.